Step 1 topics → Respiratory → Sarcoidosis

Sarcoidosis

USMLE Step 1 trap: Confuses sarcoidosis granulomas with the caseating granulomas of tuberculosis. Sarcoidosis granulomas are non-caseating (non-necrotizing), which distinguishes them from TB and other infectious granulomas.

Sarcoidosis is a systemic granulomatous disease of unknown cause — almost certainly immune-mediated — characterized by non-caseating granulomas that can infiltrate virtually any organ. On USMLE Step 1, this is a high-yield topic tested from multiple angles: you need to recognize the pathology, explain the mechanism behind its lab findings (especially hypercalcemia), interpret imaging, and know when to treat versus observe. The classic patient is a young Black woman in her 20s–40s presenting with bilateral hilar adenopathy on chest X-ray, fatigue, and a laundry list of multi-system findings — but don't let that narrow your pattern matching too much.

What makes sarcoidosis tricky is that students memorize facts in isolation without connecting the mechanism. Why is there hypercalcemia? Why is ACE elevated? Why is there a CD4:CD8 ratio increase on BAL? These aren't random — they all flow from the same thing: activated macrophages clustering into granulomas and doing things macrophages normally aren't supposed to do at that scale. The exam loves to test whether you understand those connections, not just whether you can recite 'bilateral hilar adenopathy.'

The other trap is confusing sarcoidosis with tuberculosis. Both cause granulomatous inflammation, both can hit the lungs and lymph nodes, both can cause constitutional symptoms — but the granulomas are fundamentally different (caseating vs. non-caseating), and USMLE Step 1 will absolutely test this distinction. Lofgren syndrome (bilateral hilar adenopathy + erythema nodosum + arthritis + fever) and uveoparotid fever (uveitis + parotid enlargement) are named syndromes you need to recognize cold.

From real student decks
95%have cards covering this topic
89%have mature cards

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake
Wrong: Sarcoidosis granulomas are caseating, like those in tuberculosis.
Right: Sarcoidosis granulomas are non-caseating (non-necrotizing), which distinguishes them from TB and other infectious granulomas.
Sarcoidosis granulomas are non-caseating — there is no central necrosis. Caseating (necrotizing) granulomas are the hallmark of TB and some fungal infections like histoplasmosis. When you see 'caseating' on a question stem, think infection; when you see 'non-caseating,' think sarcoidosis (or berylliosis, Crohn's). This distinction is a direct exam target on USMLE Step 1 and getting it wrong on a path question can cascade into wrong answers on mechanism and treatment.
Common mistake
Wrong: Hypercalcemia in sarcoidosis is caused by increased PTH secretion.
Right: Hypercalcemia in sarcoidosis results from ectopic 1-α-hydroxylase activity in activated macrophages within granulomas, converting 25-OH vitamin D to calcitriol independently of PTH.
The hypercalcemia in sarcoidosis is PTH-independent. Activated macrophages within granulomas express 1-α-hydroxylase ectopically, converting 25-OH vitamin D into active calcitriol on their own — no kidney, no PTH signal needed. Because calcium and calcitriol rise, PTH is actually suppressed via negative feedback. If a question describes a sarcoidosis patient with hypercalcemia and asks for the mechanism, the answer is granuloma-derived 1-α-hydroxylase, not PTH excess — that's a completely different pathway (primary hyperparathyroidism).
Common mistake
Wrong: An elevated serum ACE level is diagnostic of sarcoidosis.
Right: Elevated serum ACE has poor specificity (also elevated in TB, berylliosis, histoplasmosis) and is used for monitoring disease activity, not diagnosis.
Serum ACE is elevated in sarcoidosis because activated macrophages in granulomas produce it — but so do macrophages in TB, berylliosis, histoplasmosis, and other granulomatous diseases. This makes ACE a poor diagnostic test (low specificity). Its real clinical use is tracking disease activity over time in a known sarcoidosis patient: a rising ACE suggests progression, a falling ACE suggests response to treatment. Never use ACE to confirm a new diagnosis of sarcoidosis on the exam — tissue biopsy showing non-caseating granulomas is the gold standard.
Common mistake
Wrong: All sarcoidosis patients require immediate corticosteroid treatment at diagnosis.
Right: Asymptomatic sarcoidosis (especially stage I–II) often remits spontaneously and warrants observation; corticosteroids are reserved for symptomatic, progressive, or organ-threatening disease.
Not every sarcoidosis patient needs steroids. Many patients — particularly those with stage I (bilateral hilar adenopathy alone) or even stage II — experience spontaneous remission without treatment. Reflexively starting corticosteroids ignores this and exposes patients to steroid side effects unnecessarily. Reserve treatment for symptomatic disease, evidence of progression, or involvement of high-stakes organs: cardiac sarcoid causing arrhythmia or heart block, neurosarcoidosis, severe ocular involvement, or significant pulmonary impairment. The exam tests whether you know the 'observe first' strategy, not just that steroids are the drug.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Identify the type of granuloma in sarcoidosis and know what BAL findings (elevated CD4:CD8 ratio) differentiate it from other interstitial lung diseases.
  2. Recognize sarcoidosis across its multi-system presentations — pulmonary, ocular (uveitis), cutaneous (erythema nodosum, lupus pernio), cardiac (heart block), neurological (facial nerve palsy), and the named syndromes Lofgren and uveoparotid fever.
  3. Interpret characteristic labs and imaging: bilateral hilar adenopathy on CXR, elevated serum ACE, elevated 24-hr urine calcium, and understand the staging system (I–IV) and what each stage implies.
  4. Explain the mechanism of hypercalcemia: ectopic 1-α-hydroxylase in activated macrophages converts 25-OH vitamin D to calcitriol, driving calcium absorption independent of PTH — and know that PTH will therefore be suppressed, not elevated.
  5. Decide when to treat versus observe: asymptomatic or mild disease often self-resolves and warrants watchful waiting; systemic corticosteroids are indicated for symptomatic, progressive, or organ-threatening disease (cardiac, neuro, ocular).

Can you avoid these mistakes?

A 32-year-old Black woman presents with bilateral hilar adenopathy, uveitis, and parotid gland swelling. Biopsy of a lung lesion shows granulomas without central necrosis. What single enzyme expressed by cells within these granulomas best explains why her serum calcium is elevated — and what would you expect her PTH level to be?
A pathology slide shows tight clusters of epithelioid macrophages and multinucleated giant cells without any central cheesy necrosis. What disease process does this pattern suggest, and how does it differ from what you would see in active pulmonary tuberculosis?
A patient with known sarcoidosis has an elevated serum ACE level. A classmate says this confirms active sarcoidosis. What is wrong with this reasoning, and what is the appropriate clinical use of serum ACE in sarcoidosis?
A 28-year-old woman is incidentally found to have bilateral hilar adenopathy on a chest X-ray done for an unrelated reason. She has no symptoms and normal pulmonary function tests. Biopsy confirms non-caseating granulomas consistent with stage I sarcoidosis. What is the most appropriate next step — and under what circumstances would that management change?

Related topics

Lung Development Stages Surfactant Production and Neonatal RDS Bronchopulmonary Dysplasia Congenital Diaphragmatic Hernia

See how your Anki deck covers this topic.

Upload your deck for a free audit →